← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2011First marketed drug
Jul 25, 2019First NDA
Jul 25, 2019Last known activity
Oct 4, 2021
Timeline
2000s
- Jun 1, 2008
Shield Therapeutics— Founded
2010s
- Jul 25, 2019
ferric maltol— Marketing Organization
- Jul 25, 2019
ferric maltol— NDA Organization
Drugs by trial phase (4 distinct, 8 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (15)
- NCT05126901Lead sponsorPhase 3Oct 4, 2021
- NCT04626414Study directorPhase 1Sep 28, 2020
- NCT04626414Lead sponsorPhase 1Sep 28, 2020
- NCT03181451Study directorPhase 1Mar 14, 2017
- NCT03181451Lead sponsorPhase 1Mar 14, 2017
- NCT02968368Study directorPhase 3Nov 1, 2016
- NCT02968368Lead sponsorPhase 3Nov 1, 2016
- NCT02680756Lead sponsorPhase 3Jan 1, 2016
- NCT02680756Study directorPhase 3Jan 1, 2016
- NCT02151643Lead sponsorPhase 2May 1, 2014
- NCT02151643Study directorPhase 2May 1, 2014
- NCT01340872Study directorPhase 3Aug 1, 2011
- NCT01352221Study directorPhase 3Aug 1, 2011
- NCT01352221Lead sponsorPhase 3Aug 1, 2011
- NCT01340872Lead sponsorPhase 3Aug 1, 2011
Details
- Founded
- Weybridge, GB Jun 1, 2008
- First NDA
- Jul 25, 2019
- Last known activity
- Oct 4, 2021